Skip to main content
. Author manuscript; available in PMC: 2011 Oct 19.
Published in final edited form as: Circulation. 2010 Oct 4;122(16):1578–1587. doi: 10.1161/CIRCULATIONAHA.109.879338

Table 1.

Changes in neurologic disability of animals with ischemia on day 1 and day 3 after transient MCA occlusion.

Treatment Group Limb Placement Beam Walking Grid Walking
Day 1 Day 3 Day 1 Day 3 Day 1 Day 3
Med 25% 75% Med 25% 75% Med 25% 75% Med 25% 75% Med 25% 75% Med 25% 75%
Normal (No Hypoxia) 2.0* 2.0 2.0 2.0* 2.0 2.0 1.0* 1.0 1.0 1.0* 1.0 1.3 0.5* 0.0 1.3 0.5* 0.0 1.3
No Treatment 0.0 0.0 0.0 1.0 0.8 1.0 5.0 4.8 5.0 4.5 4.0 5.0 47 46 48 45 42 47
Xe-Solution Treatment 1.0* 1.0 1.0 2.0* 2.0 2.0 2.5* 2.0 3.0 2.0* 2.0 2.0 5.0* 4.8 6.3 3.0* 2.8 3.3
Xe-ELIP Treatment 1.0* 1.0 1.0 2.0* 2.0 2.0 4.0++ 4.0 4.0 3.0** 3.0 4.0 10* 10 12 7.5* 6.0 8.3
Xe-ELIP Treatment + US Exposure 1.5* 1.0 2.0 2.0* 2.0 2.0 3.5+ 3.0 4.0 2.0* 2.0 3.0 8.0* 7.8 8.8 4.0* 3.0 5.3

Data are presented as median and quartiles, US – ultrasound.

*

p<0.001,

**

p=0.002,

+

p=0.01,

++

p=0.03 vs. No treatment group, n=8.

Scores in the limb placement: 0 – no response; 1 – response was sluggish or delayed; 2 response was rapid and fully executed.

Scores in the beam walking: 0 – traversed the beam with no foot slip; 1 – traversed with grasping of the lateral side of the beam; 2 – showed difficulty crawling across the beam but able to traverse; 3 – required a more than 10 seconds to traverse the beam due to difficulty in walking; 4 – unable to traverse the beam; 5 – unable to move the body or any limb on the beam; 6 – unable to stay on the beam for more than 10 seconds.

Scores in the grid walking: Total number of foot fault errors.